The Anethi Extract segmentation by application delineates four primary end‑use categories that together define the market’s revenue composition. Food & Beverages accounts for roughly 40 % of total sales, driven by the extract’s antioxidant properties that extend shelf‑life and enhance functional claims in beverages, dairy, and bakery products. Cosmetics represents the second largest share at 30 %, where formulators exploit the skin‑protective and anti‑aging effects of Anethi compounds in creams, serums, and sunscreens, contributing a high‑margin revenue stream. Pharmaceuticals hold a 20 % share, reflecting clinical investigations into anti‑inflammatory and neuroprotective activities that justify premium pricing and regulatory‑driven adoption. Finally, Nutraceuticals comprise the remaining 10 %, primarily as dietary supplements and fortified foods targeting health‑conscious consumers. Each application segment’s distinct regulatory pathways, pricing structures, and distribution channels collectively shape the overall market size, with the proportional weighting directly influencing production volume, R&D allocation, and profit margins across the Anethi Extract value chain.